Author Archive: BIOtechNOW Editor

Propel Small Business Innovation through Tax Reform

Jeffery_Hatfield copy

As CEO of an emerging clinical-stage biotech company, I lose over $10 million each year. Over the lifetime of my company, I have lost over $100 million. But constantly losing money in an effort to advance discoveries should not overshadow the real lifeblood of biotechnology, which is the reward of seeing patients treated, lives saved, and families healed. Some of the biggest challenges companies like mine face include high research and production costs, coupled with Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

How the Orphan Drug Tax Credit Leverages MDA’s Fight against Rare Genetic Diseases

dna_peoplefigures

In the early 1950s, a small group of concerned parents, people with muscular dystrophy and their friends started a volunteer organization, the Muscular Dystrophy Association (MDA), to raise money for research into the causes of rare genetic diseases that mysteriously destroyed muscles and shortened lives. In the decades since — thanks to the support of a caring public and vital corporate partnerships — MDA has become a leading voluntary health agency, funding research in academic Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

When is the Evidence “Enough” to Make a Health Care Decision?

Protein_BRCA1_PDB_1jm7

At any given time, work is taking place in hundreds of laboratories throughout the country to develop new and better ways of combating disease and protecting our health and well-being.  As the results of this research becomes more widely known, how long does it take before this new information changes the actual practice of medicine in hospitals, clinics and physicians’ offices? According to the Institute of Medicine, it takes an average of 17 years for Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

The Michael J. Fox Foundation Launches $10 Million Edmond J. Safra Core Programs

Moving Inside the Beltway: Brief Health Roundup

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has committed up to $10 million to its next funding round for the Edmond J. Safra Core Programs for PD Research to prioritize research toward transformative treatments and a cure for Parkinson’s disease (PD). We invite qualified researchers to apply to the Edmond J. Safra Core Programs for PD Research: Rapid Response Innovation Awards: This program supports high-risk, high-reward projects with little-to-no existing preliminary data, but with potential to significantly Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

New BIO Survey on Effective FDA – Sponsor Communication During Drug Development

BIO Logo Horizontal 4C copy

BIO is surveying members on their interactions with the FDA during the various stages of drug development prior to submitting an NDA/BLA. The survey can be accessed here. In an increasingly competitive and fiscally-constrained environment, it is more important than ever for all stakeholders to work together to promote effective R&D for innovative medicines. This initial survey is designed to assist in the implementation of the Prescription Drug User Fee Act (PDUFA V) program on Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,